GWPH Profile
- Sector: Health Technology
- Industry: Pharmaceuticals: Other
- Employees: 901
GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.
[bbp-topic-index] [bbp-topic-form]Recent News
FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease
— Today, the U.S. Food and Drug Administration approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) …
GW Pharmaceuticals announces that EPIDYOLEX® (cannabidiol) has been reclassified by the UK Home Office as a Schedule 5 drug
GW’s cannabis-based medicine rescheduled following approval by the European Medicines Agency (EMA) and an independent assessment by the Advisory Council on the Misuse of Drugs …
GW Pharmaceuticals plc Reports First Quarter 2020 Financial Results and Operational Progress
– Total revenue of $120.6 million – – Total Epidiolex® net product sales of $116.1 million – – Conference call today at 4:30 p.m. EDT – LONDON …
- Premium 5 Products Are Coming to B.C.
- Neptune Receives U.S. EPA Company Number for Registration of Surface Disinfectant Wipes
- Emerald Health Therapeutics Announces New At-the-Market Equity Program
- Yield Growth Announces Name Change and Provides Corporate Update
- Green Thumb Industries Reports Second Quarter 2020 Results
- Hexo Corp. Completes C$34.5 Million At-the-Market Offering Program
- The Green Organic Dutchman Announces Q2-2020 Results
- Village Farms International Reports Second Quarter 2020 Financial Results – Pure Sunfarms Achieves Sixth Consecutive Profitable Quarter on 89% Sequential Increase in Retail Branded Sales Volume – Produce Business Generates Positive Adjusted EBITDA
- GTEC Launches Recreational Cannabis Brands Tenzo and BLK MKT in Ontario
- 1933 Industries Launches Canna Hemp™ PLUS Line with Double the Amount of CBD and a Renewed Focus on Health and Wellness
All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. Candlr is not receiving payment or commissions from companies for shared content on Candlr website unless its specified. View full disclaimer HERE.
[bbp-topic-index]